dr. W. Noordzij

No picture available
E-mail:
w.noordzij umcg.nl

Research

  1. 2020
  2. Privé, B. M., Janssen, M. J. R., van Oort, I. M., Muselaers, C. H. J., Jonker, M. A., de Groot, M., ... Nagarajah, J. (2020). Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial. BMC Cancer, 20(1), [884]. https://doi.org/10.1186/s12885-020-07386-z
  3. Dutch Oligometastatic Prostate Cancer Working Group, Aluwini, S. S., Mehra, N., Lolkema, M. P., Oprea-Lager, D. E., Yakar, D., ... van der Poel, H. (2020). Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting. European urology oncology, 3(2), 231-238. https://doi.org/10.1016/j.euo.2019.07.010
  4. 2019
  5. 2018
  6. Targeted Alpha Therapy Working Grp, Parker, C., Lewington, V., Shore, N., Kratochwil, C., Levy, M., ... Saad, F. (2018). Targeted Alpha Therapy, an Emerging Class of Cancer Agents A Review. JAMA Oncol, 4(12), 1765-1772. https://doi.org/10.1001/jamaoncol.2018.4044
Previous 1 2 Next

ID: 497045